IP Library Granted Patent US 12,290,666
Granted Patent B2
US 12,290,666 · App. 17/277,555 · Granted May 6, 2025

Drug delivery devices with partial needle retraction

Inventors: Ali Nekouzadeh (Simi Valley, CA); Carl Conrath (Thousand Oaks, CA); Basel Hasan Taha (Simi Valley, CA)
Assignee: AMGEN INC.
A61M5/31511A61M5/2033A61M5/31501
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,290,666
App. No.
17/277,555
Granted
May 6, 2025
Kind
B2
Abstract

Methods, devices, and components are provided to reduce tissue resistive pressure during a subcutaneous drug delivery operation by increasing the size of the injection cavity by partially retracting the drug delivery member after inserting the drug delivery member to a subcutaneous position. The drug delivery devices described herein include a resilient member that interacts between stationary and moveable components of the drug delivery device. The drug delivery device include drives to move the stationary and moveable components relative to one another to insert a drug delivery member to a subcutaneous depth within a patient and to dispense a drug to the injection cavity in the patient. The resilient member is deformed during the operations or is pre-deformed and the stored energy of the resilient member in the deformed state then acts on the stationary and moveable components to partially retract the drug delivery member to relieve pressure in the injection region.

Claims (15)

1. A drug delivery device comprising:

an outer casing including one or more sidewalls, a distal end wall, and a proximal end wall defining an interior, the distal end wall having an opening extending therethrough;

a primary container assembly at least partially received within the interior of the outer casing, the primary container assembly including a reservoir having a sidewall defining an interior containing a drug to be expelled, a plunger stopper disposed within the interior of the reservoir to expel the drug therefrom, and a drug delivery member operably connected to the reservoir and configured to be fluidly coupled to the interior thereof, at least the drug delivery member being movable between first and second positions with respect to the outer casing; and

a resilient member disposed between the primary container assembly and the outer casing, wherein upon moving the drug delivery member to the second position in which the delivery member is driven through the opening and prior to the plunger stopper expelling the drug from the interior of the reservoir, the resilient member is in a deformed state that biases the drug delivery member to move in a retraction direction toward the first position to partially retract the drug delivery member to a retracted position, whereby the plunger stopper expels the drug from the interior of the reservoir while the drug delivery member is in the retracted position.

2. The drug delivery device of claim 1 , wherein the primary container assembly includes a distal end, and the resilient member is disposed between the distal end of the primary container assembly and the distal end wall of the outer casing.

3. The drug delivery device of claim 2 , wherein the distal end of the primary container assembly comprises a distal end of the reservoir or the primary container assembly further includes a housing at least partially receiving the reservoir and drug delivery member therein and the distal end of the primary container assembly comprises a distal end of the housing.

4. The drug delivery device of claim 1 , wherein the primary container assembly includes an outwardly projecting flange at a proximal end thereof opposite the drug delivery member; the outer casing includes an inwardly projecting flange; and the resilient member is disposed between the outwardly and inwardly projecting flanges.

5. The drug delivery device of claim 4 , wherein the proximal end of the primary container assembly comprises a proximal end of the reservoir.

6. The drug delivery device of claim 4 , wherein the primary container assembly further includes a housing at least partially receiving the reservoir and drug delivery member therein; and the proximal end of the primary container assembly comprises a proximal end of the housing.

7. The drug delivery device of claim 1 , wherein the resilient member comprises a spring or an elastomeric bumper.

8. The drug delivery device of claim 1 , wherein the resilient member comprises one or more cantilevered tabs extending inwardly from the one or more sidewalls of the outer casing, the cantilevered tabs including inward end portions disposed within a path of the primary container assembly.

9. The drug delivery device of claim 1 , further comprising a drive mechanism configured to drive movement of the drug delivery member with respect to the outer casing in an insertion direction from the first position to the second position such that the drug delivery member extends through the opening in the distal end wall of the outer casing for a drug delivery member insertion operation.

10. The drug delivery device of claim 9 , wherein the drive mechanism further comprises a drive rod, the drive mechanism configured to drive the plunger rod to drive movement of the plunger stopper through the reservoir to expel a drug through the drug delivery member during a drug delivery operation; and the plunger stopper being driven through the reservoir causes the resilient member to deform and bias the primary container assembly to move in the second, opposite direction with respect to the outer casing to partially retract the drug delivery member after the drug delivery operation.

11. The drug delivery device of claim 1 , further comprising a release member engaging the primary container assembly or both the primary container assembly and the resilient member; and wherein the resilient member is held in the deformed state by the release member.

12. The drug delivery device of claim 1 , further comprising a locking mechanism including a lock member deflectable by the primary container assembly as the primary container assembly is moved in the retraction direction and a biasing mechanism configured to bias the lock member into a path of a portion of the primary container assembly in the insertion direction to restrict further movement of the primary container assembly.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2021
From: NEKOUZADEH, ALI; CONRATH, CARL; TAHA, BASEL HASAN
To: AMGEN INC.
Reel/Frame 056839/0550 →
Continuity (2)
Provisional Application 62754362 · Nov 1, 2018
Related Publication 20220031953A1 · Feb 3, 2022
References Cited (32)
US 3316909A · Cowley · 1967 [cited by applicant]
US 3720211A · Kyrias · 1973 [cited by applicant]
US 3797489A · Sarnoff · 1974 [cited by applicant]
US 4699612A · Hamacher · 1987 [cited by applicant]
US 6478768B1 · Kneer · 2002 [cited by applicant]
US 8795230B2 · Schoonmaker et al. · 2014 [cited by applicant]
US 9814840B2 · Cowe et al. · 2017 [cited by applicant]
US 9844635B2 · Schoonmaker et al. · 2017 [cited by applicant]
US 9849252B2 · Armes · 2017 [cited by applicant]
US 20100076400A1 · Wall · 2010 [cited by applicant]
US 20150174326A1 · Bokelman et al. · 2015 [cited by applicant]
US 20160128576A1 · Chiang et al. · 2016 [cited by applicant]
US 20160256106A1 · Krasnow et al. · 2016 [cited by applicant]
US 20160302868A1 · Nagale et al. · 2016 [cited by applicant]
US 20170106146A1 · Folk · 2017 [cited by examiner]
US 20170216526A1 · Brereton et al. · 2017 [cited by applicant]
US 20180021508A1 · Destefano et al. · 2018 [cited by applicant]
CN 103249443B · 2015 [cited by applicant]
GB 2550924A · 2017 [cited by applicant]
KR 101776258B1 · 2017 [cited by applicant]
TW 201315499A · 2013 [cited by applicant]
WO WO2012045831A1 · 2012 [cited by applicant]
WO WO2013028906A1 · 2013 [cited by applicant]
WO WO2014150201A1 · 2014 [cited by applicant]
WO WO2015171777A1 · 2015 [cited by applicant]
WO WO2016003813A1 · 2016 [cited by applicant]
WO WO2018055433A1 · 2018 [cited by applicant]
WO WO2018136398A1 · 2018 [cited by applicant]
WO WO2019081947A1 · 2019 [cited by applicant]
International Search Report and Written Opinion for International Patent Application No. PCT/US2019/055010, dated Jan. 20, 2020. [cited by applicant]
International Application No. PCT/US2019/057370, International Search Report and Written Opinion, mailed Jan. 27, 2020. [cited by applicant]
International Application No. PCT/US2019/056073, International Search Report and Written Opinion, mailed Feb. 3, 2020. [cited by applicant]